Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | PCVX | QGEN | ||
| Company | Blueprint Medicines Corp | Vaxcyte Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 129.35 | 58.11 | 40.27 | ||
| High | 129.55 | 59.69 | 40.63 | ||
| Low | 129.30 | 57.46 | 40.19 | ||
| Latest | 129.46 | 58.50 | 40.38 | ||
| Change | +0.18 | +0.39 | +0.34 | ||
| % Change | +0.14% | +0.67% | +0.85% | ||
| Volume | 2,980,900 | 2,691,600 | 1,126,700 | ||
| 20-Day Average Volume | 4,470,280 | 1,383,725 | 2,046,160 | ||
| Previous Close | 129.28 | 58.11 | 40.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 56.17 | 41.11 | ||
| 20-Day Raw Stochastic | 88.49% | 74.71% | 19.34% | ||
| 20-Day Relative Strength | 73.17 | 56.00 | 35.78 | ||
| Weighted Alpha | +17.08 | +83.76 | -11.82 | ||
| Today's Opinion | 100% Buy | 72% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +4.63% since 03/25/26 | -0.62% since 03/25/26 | ||
| Low | 129.00 on 07/11/25 | 52.74 on 03/30/26 | 38.79 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 59.69 on 04/01/26 | 40.92 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | -5.25% since 02/27/26 | -18.92% since 02/27/26 | ||
| Low | 128.00 on 06/20/25 | 52.74 on 03/30/26 | 38.79 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 62.55 on 03/02/26 | 49.71 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +26.79% since 12/31/25 | -14.70% since 12/31/25 | ||
| Low | 83.27 on 04/22/25 | 43.94 on 01/05/26 | 38.79 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 65.00 on 02/25/26 | 57.81 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +53.83% since 10/01/25 | -17.18% since 10/01/25 | ||
| Low | 73.04 on 04/09/25 | 37.69 on 10/02/25 | 38.79 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 65.00 on 02/25/26 | 57.81 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,363,190 | 8,251,243 | ||
| Shares Outstanding, K | 64,582 | 143,920 | 206,075 | ||
| Annual Sales | 508,820,000 | 0 | 2,090,000,000 | ||
| Annual Net Income | -67,090,000 | -766,630,000 | 424,880,000 | ||
| Last Quarter Sales | 149,410,000 | 0 | 540,420,000 | ||
| Last Quarter Net Income | 500,000 | -246,510,000 | 107,830,000 | ||
| 60-Month Beta | 0.89 | 1.31 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | -1.80 on 02/24/26 | 0.62 on 02/04/26 | ||
| Latest Earnings Date | 08/07/25 | 05/06/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.90 | ||